Immune reactivity in head and neck squamous carcinoma and relevance to the design of immunotherapy trials.
D001500:BCG Vaccine / Q000627:therapeutic use; D002294:Carcinoma, Squamous Cell / Q000276:immunology* / Q000473:pathology / Q000628:therapy; D004137:Dinitrochlorobenzene / Q000276:immunology; D006258:Head and Neck Neoplasms / Q000276:immunology* / Q000473:pathology / Q000628:therapy; D006801:Humans; D007111:Immunity, Cellular; D007167:Immunotherapy; D037102:Lectins; D007978:Levamisole / Q000627:therapeutic use; D008207:Lymphatic Metastasis; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000276:immunology; D011379:Prognosis; D012882:Skin Tests
D001500:BCG Vaccine; D004137:Dinitrochlorobenzene; D037102:Lectins; D007978:Levamisole